Literature DB >> 27668597

[The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016].

P Pumpens1, E Grens1,2.   

Abstract

This review article is a continuation of the paper "Hepatitis B core particles as a universal display model: a structure-function basis for development" written by Pumpens P. and Grens E., ordered by Professor Lev Kisselev and published in FEBS Letters, 1999, 442, 1-6. The past 17 years have strengthened the paper's finding that the human hepatitis B virus core protein, along with other Hepadnaviridae family member core proteins, is a mysterious, multifunctional protein. The core gene of the Hepadnaviridae genome encodes five partially collinear proteins. The most important of these is the HBV core protein p21, or HBc. It can self-assemble by forming viral HBc particles, but also plays a crucial role in the regulation of viral replication. Since 1986, the HBc protein has been one of the first and the most successful tools of the virus-like particle (VLP) technology. Later, the woodchuck hepatitis virus core protein (WHc) was also used as a VLP carrier. The Hepadnaviridae core proteins remain favourite VLP candidates for the knowledge-based design of future vaccines, gene therapy vectors, specifically targeted nanocontainers, and other modern nanotechnological tools for prospective medical use.

Entities:  

Keywords:  3D structure; core protein; hepatitis B; immunology; self-assembly; viral nanotechnology; virus-like particles

Year:  2016        PMID: 27668597     DOI: 10.7868/S0026898416040091

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  10 in total

1.  Escherichia coli-derived virus-like particles in vaccine development.

Authors:  Xiaofen Huang; Xin Wang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  NPJ Vaccines       Date:  2017-02-09       Impact factor: 7.344

2.  Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.

Authors:  Izzat Fahimuddin Bin Mohamed Suffian; Julie Tzu-Wen Wang; Naomi O Hodgins; Rebecca Klippstein; Mitla Garcia-Maya; Paul Brown; Yuya Nishimura; Hamed Heidari; Sara Bals; Jane K Sosabowski; Chiaki Ogino; Akihiko Kondo; Khuloud T Al-Jamal
Journal:  Biomaterials       Date:  2016-12-14       Impact factor: 12.479

Review 3.  Harnessing Nanoparticles for Immunomodulation and Vaccines.

Authors:  Ariane C Gomes; Mona Mohsen; Martin F Bachmann
Journal:  Vaccines (Basel)       Date:  2017-02-14

4.  Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.

Authors:  Andris Kazaks; I-Na Lu; Sophie Farinelle; Alex Ramirez; Vincenzo Crescente; Benjamin Blaha; Olotu Ogonah; Tarit Mukhopadhyay; Mapi Perez de Obanos; Alejandro Krimer; Inara Akopjana; Janis Bogans; Velta Ose; Anna Kirsteina; Tatjana Kazaka; Nicola J Stonehouse; David J Rowlands; Claude P Muller; Kaspars Tars; William M Rosenberg
Journal:  BMC Biotechnol       Date:  2017-11-10       Impact factor: 2.563

Review 5.  SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies.

Authors:  Lanxiang Huang; Yuan Rong; Qin Pan; Kezhen Yi; Xuan Tang; Qian Zhang; Wei Wang; Jianyuan Wu; Fubing Wang
Journal:  Asian J Pharm Sci       Date:  2020-09-01       Impact factor: 6.598

6.  Expression of quasi-equivalence and capsid dimorphism in the Hepadnaviridae.

Authors:  Weimin Wu; Norman R Watts; Naiqian Cheng; Rick Huang; Alasdair C Steven; Paul T Wingfield
Journal:  PLoS Comput Biol       Date:  2020-04-20       Impact factor: 4.475

7.  Preparation and preliminary evaluation of hepatitis B core antigen virus like nanoparticles loaded with indocyanine green.

Authors:  Yunlong Wang; Yiqing Zhang; Yinyin Yu; Lei Ren; Jichuang Wang; Lei Cheng; Dandan Jiang; Xiangqian Guo; Tieshan Teng; Xiaoyong Luo; Shuangyu Lv; Xudong Wang; Huirui Wang; Xinpeng Shi; Heng Zhang; Shengli Bi
Journal:  Ann Transl Med       Date:  2020-12

8.  Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA.

Authors:  Ivars Petrovskis; Ilva Lieknina; Andris Dislers; Juris Jansons; Janis Bogans; Inara Akopjana; Jelena Zakova; Irina Sominskaya
Journal:  Microorganisms       Date:  2021-01-30

Review 9.  Plant-Based Vaccines in Combat against Coronavirus Diseases.

Authors:  Benita Ortega-Berlanga; Tomasz Pniewski
Journal:  Vaccines (Basel)       Date:  2022-01-18

10.  Do we need better hepatitis B vaccines?

Authors:  Wolfram H Gerlich
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.